Newamsterdam Pharma Company N.V. (NAMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,385 | 4,179 | 3,249 | 1,519 | 2,818 |
| Accounts payable and accrued liabilities | -115 | 5 | -117 | -98 | -1 |
| Other Working Capital | -49 | 228 | 182 | -33 | 35 |
| Other Operating Activity | -1,615 | -4,550 | -4,043 | -1,964 | -3,055 |
| Operating Cash Flow | $-394 | $-138 | $-730 | $-576 | $-203 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -45 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $-45 | $N/A | $N/A | $N/A | $N/A |
| Beginning Cash Position | 1,227 | 1,365 | 1,365 | 1,365 | 1,365 |
| End Cash Position | 788 | 1,227 | 636 | 790 | 1,163 |
| Net Cash Flow | $-439 | $-138 | $-730 | $-576 | $-203 |
| Free Cash Flow | |||||
| Operating Cash Flow | -394 | -138 | -730 | -576 | -203 |
| Free Cash Flow | -394 | -138 | -730 | -576 | -203 |